London pre-open: Stocks seen weaker on Asian cues even as lockdown easing begins
(Sharecast News) - London stocks were set to fall at the open on Monday, taking their cue from weaker Asian markets even as lockdown restrictions in England eased.
The FTSE 100 was called to open 17 points lower at 6,898
CMC Markets analyst Michael Hewson said: "For now, European stocks look set to open lower despite the strong finish in the US, as markets in Asia came under pressure ahead of a key week for Chinese data, against a backdrop of concern that Chinese officials are now looking at cracking down on some of the frothier parts of the Chinese economy, as they look to take measures to rein back on leverage, as well as increasing regulation.
"A $2.8bn fine by Chinese regulators on Alibaba saw their shares surprisingly rise, however its counterparts in the sector, the likes of Tencent, JD.com and Baidu have slid back.
"The higher finish in the US occurred, despite a sharp move higher in US and Chinese factory gate prices in March, with both the Dow and S&P500 closing at record highs, though it is also noteworthy that the Nasdaq and Russell 2000 have lagged behind their larger counterparts."
In corporate news, shopping centre owner Hammerson confirmed it was in talks with Canadian private equity firm Brookfield on a possible sale of its retail parks. Brookfield will pay around £350m for seven retail parks, the Sunday Times reported.
"There can be no certainty that a transaction will take place or the terms on which any transaction may occur. The company will provide a further update in due course, if appropriate," Hammerson said in a statement.
AstraZeneca said a trial of its Farxiga drug for treating hospitalised Covid-19 patients did not produce statistically significant results.
"The trial did not achieve statistical significance for the primary endpoint of prevention measuring organ dysfunction and all-cause mortality, and the primary endpoint of recovery measuring a change in clinical status (from early recovery to death), at 30 days," the company said.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.